Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Frontiers in Neurology
|
July 17, 2020
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
Jyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, et al.
Acta Neuropathologica Communications
|
December 7, 2017
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
Maciej Jurynczyk, Fay Probert, Tianrong Yeo, et al.
Brain : a Journal of Neurology
|
May 23, 2018
Distinct HLA associations of LGI1 and CASPR2-antibody diseases
Sophie Binks, James Varley, Wanseon Lee, et al.
The Lancet. Neurology
|
April 20, 2026
Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association study
Kathrine E Attfield, Angelos P Armen, Subita Balaram Kuttikkatte, et al.
Nature Reviews. Neurology
|
September 3, 2024
The influence of MOGAD on diagnosis of multiple sclerosis using MRI
Ruth Geraldes, Georgina Arrambide, Brenda Banwell, et al.
JAMA Neurology
|
January 7, 2018
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Yael Hacohen, Yu Yi Wong, Christian Lechner, et al.
The Lancet. Neurology
|
April 14, 2023
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
James F Howard, Saskia Bresch, Angela Genge, et al.
Therapeutic Advances in Neurological Disorders
|
April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
James F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 31, 2023
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab
Friedemann Paul, Romain Marignier, Jacqueline Palace, et al.
The Lancet. Psychiatry
|
December 12, 2025
The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis
Adam Al-Diwani, Jakob Theorell, Tarek Zghoul, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Frontiers in Neurology
|
July 17, 2020
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
Jyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, et al.
Acta Neuropathologica Communications
|
December 7, 2017
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
Maciej Jurynczyk, Fay Probert, Tianrong Yeo, et al.
Brain : a Journal of Neurology
|
May 23, 2018
Distinct HLA associations of LGI1 and CASPR2-antibody diseases
Sophie Binks, James Varley, Wanseon Lee, et al.
The Lancet. Neurology
|
April 20, 2026
Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association study
Kathrine E Attfield, Angelos P Armen, Subita Balaram Kuttikkatte, et al.
Nature Reviews. Neurology
|
September 3, 2024
The influence of MOGAD on diagnosis of multiple sclerosis using MRI
Ruth Geraldes, Georgina Arrambide, Brenda Banwell, et al.
JAMA Neurology
|
January 7, 2018
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Yael Hacohen, Yu Yi Wong, Christian Lechner, et al.
The Lancet. Neurology
|
April 14, 2023
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
James F Howard, Saskia Bresch, Angela Genge, et al.
Therapeutic Advances in Neurological Disorders
|
April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
James F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 31, 2023
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab
Friedemann Paul, Romain Marignier, Jacqueline Palace, et al.
The Lancet. Psychiatry
|
December 12, 2025
The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis
Adam Al-Diwani, Jakob Theorell, Tarek Zghoul, et al.
Page
of 8